Literature DB >> 23872455

K+ channel modulation causes genioglossus inhibition in REM sleep and is a strategy for reactivation.

Kevin P Grace1, Stuart W Hughes, Shahram Shahabi, Richard L Horner.   

Abstract

Rapid eye movement (REM) sleep is accompanied by periods of upper airway motor suppression that cause hypoventilation and obstructive apneas in susceptible individuals. A common idea has been that upper airway motor suppression in REM sleep is caused by the neurotransmitters glycine and γ-amino butyric acid (GABA) acting at pharyngeal motor pools to inhibit motoneuron activity. Data refute this as a workable explanation because blockade of this putative glycine/GABAergic mechanism releases pharyngeal motor activity in all states, and least of all in REM sleep. Here we summarize a novel motor-inhibitory mechanism that suppresses hypoglossal motor activity largely in REM sleep, this being a muscarinic receptor mechanism linked to G-protein-coupled inwardly rectifying potassium (GIRK) channels. We then outline how this discovery informs efforts to pursue therapeutic targets to reactivate hypoglossal motor activity throughout sleep via potassium channel modulation. One such target is the inwardly rectifying potassium channel Kir2.4 whose expression in the brain is almost exclusive to cranial motor nuclei.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genioglossus muscle; Hypoglossal motor nucleus; Medulla; Obstructive sleep apnea; Sleep

Mesh:

Substances:

Year:  2013        PMID: 23872455     DOI: 10.1016/j.resp.2013.07.011

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  19 in total

Review 1.  REM obstructive sleep apnea: risk for adverse health outcomes and novel treatments.

Authors:  Andrew W Varga; Babak Mokhlesi
Journal:  Sleep Breath       Date:  2018-09-19       Impact factor: 2.816

2.  Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects.

Authors:  Luigi Taranto-Montemurro; Bradley A Edwards; Scott A Sands; Melania Marques; Danny J Eckert; David P White; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

3.  Effect of 4-Aminopyridine on Genioglossus Muscle Activity during Sleep in Healthy Adults.

Authors:  Luigi Taranto-Montemurro; Scott A Sands; Ali Azarbarzin; Melania Marques; Camila M de Melo; Bradley A Edwards; Danny J Eckert; Ludovico Messineo; David P White; Andrew Wellman
Journal:  Ann Am Thorac Soc       Date:  2017-07

Review 4.  Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.

Authors:  Leszek Kubin
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

5.  Sleep-wake control of the upper airway by noradrenergic neurons, with and without intermittent hypoxia.

Authors:  Leszek Kubin
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

6.  Sleep and breathing. Foreword.

Authors:  James Duffin; Leszek Kubin; Jason H Mateika
Journal:  Respir Physiol Neurobiol       Date:  2013-07-20       Impact factor: 1.931

Review 7.  Neurostimulation Treatment of OSA.

Authors:  Thomaz Fleury Curado; Arie Oliven; Luiz U Sennes; Vsevolod Y Polotsky; David Eisele; Alan R Schwartz
Journal:  Chest       Date:  2018-09-14       Impact factor: 9.410

Review 8.  State-dependent and reflex drives to the upper airway: basic physiology with clinical implications.

Authors:  Richard L Horner; Stuart W Hughes; Atul Malhotra
Journal:  J Appl Physiol (1985)       Date:  2013-08-22

9.  Strategies of Functional Foods Promote Sleep in Human Being.

Authors:  Yawen Zeng; Jiazhen Yang; Juan Du; Xiaoying Pu; Xiaomen Yang; Shuming Yang; Tao Yang
Journal:  Curr Signal Transduct Ther       Date:  2014-12

10.  Homeostatic regulation through GABA and acetylcholine muscarinic receptors of motor trigeminal neurons following sleep deprivation.

Authors:  Hanieh Toossi; Esther Del Cid-Pellitero; Barbara E Jones
Journal:  Brain Struct Funct       Date:  2017-03-15       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.